comparemela.com

Latest Breaking News On - Degron therapeutics - Page 2 : comparemela.com

China Digest: 3D printing firm HBD raises $45m; biotech startup Degron closes $22m

HBD’s Series C round was led by China Life Private Equity Investment

Jing yuLily zouYong cangShanghaitech universityChina iron steel research instituteNuclear power institute of chinaChina life private equity investmentDegron therapeuticsChina life private equityZhongshan cityGuangdong provinceGree electricChina ironSteel research instituteNuclear power instituteLife private equity investment

Tessa Therapeutics takes in $126M for cell therapies, and more biotech financings

Ten biotech companies were able to raise more than $500 million in combined financing in the past week. Here’s a recap of the funding activity, which spanned AI-based drug discovery, cell therapy clinical research, cancer drug development, and more.

United statesSan diegoUnited kingdomCity ofMitsubishi tanabe pharma corporationDanish growth fundTessa therapeuticsCharm therapeuticsPrime capitalGeneral catalystKhosla venturesPennsylvania based code bioNorthpond venturesHypertension focused mineralys therapeuticsKeir venturesAriceum therapeutics

Degron Therapeutics Raises $22M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesJing yuLily zouYong cangShanghaitech universityDegron therapeuticsMed fine capitalDyee capitalBaidu ventureNeux capitalYuanbio venture

Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein Degradation Drug Discovery Platform

/PRNewswire/ Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable.

Jing yuLily zouYong cangShanghaitech universityDyee capitalBaidu ventureNeux capitalYuanbio ventureDegron therapeuticsMed fine capital

Degron Raises $22 Million to Advance Molecular-Glue-Based Protein Degradation Platform

Degron Raises $22 Million to Advance Molecular-Glue-Based Protein Degradation Platform
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesJing yuLily zouYong cangShanghaitech universityFine capitalDyee capitalBaidu ventureNeux capitalYuanbio ventureDegron therapeuticsMed fine capital

vimarsana © 2020. All Rights Reserved.